{"filing":{"accession_number":"0001104659-26-074090","cik":"0001512762","ticker":"CHRS","company_name":"Coherus Oncology, Inc.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"chrs-20260612x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926074090/chrs-20260612x8k.htm"},"events":[{"id":11106,"run_id":9737,"accession_number":"0001104659-26-074090","anchor_item_number":"4.01","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a straightforward auditor change disclosure under Item 4.01. The Audit Committee dismissed Ernst \u0026 Young LLP effective June 12, 2026, and appointed PricewaterhouseCoopers LLP as the new independent registered public accounting firm. The filing explicitly states there were no disagreements or reportable events with EY (except a previously disclosed and remediated material weakness in internal controls), indicating a routine transition rather than a conflict-driven departure. Auditor changes are material events affecting investor confidence in financial reporting oversight.","company_name":"Coherus Oncology, Inc.","ticker":"CHRS","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7607,"accession_number":"0001104659-26-074090","item_number":"4.01","item_title":"Changes in Registrant’s Certifying Accountant.","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward auditor change disclosure under Item 4.01. The Audit Committee dismissed Ernst \u0026 Young LLP effective June 12, 2026, and appointed PricewaterhouseCoopers LLP as the new independent registered public accounting firm. The filing explicitly states there were no disagreements or reportable events with EY (except a previously disclosed and remediated material weakness in internal controls), indicating a routine transition rather than a conflict-driven departure. Auditor changes are material events affecting investor confidence in financial reporting oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:42:08.428006+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7607,"accession_number":"0001104659-26-074090","item_number":"4.01","item_title":"Changes in Registrant’s Certifying Accountant.","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward auditor change disclosure under Item 4.01. The Audit Committee dismissed Ernst \u0026 Young LLP effective June 12, 2026, and appointed PricewaterhouseCoopers LLP as the new independent registered public accounting firm. The filing explicitly states there were no disagreements or reportable events with EY (except a previously disclosed and remediated material weakness in internal controls), indicating a routine transition rather than a conflict-driven departure. Auditor changes are material events affecting investor confidence in financial reporting oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:42:08.428006+00:00","company_name":"Coherus Oncology, Inc.","ticker":"CHRS","filing_date":"2026-06-15"}]}